FDA approves new nasal spray for migraines
The Food and Drug Administration has approved a new nasal spray from Pfizer to treat migraines. Zavzpret is expected to be available in July.
Watch CBS News
The Food and Drug Administration has approved a new nasal spray from Pfizer to treat migraines. Zavzpret is expected to be available in July.
The Food and Drug Administration has issued a warning about a shortage in albuterol as well as the active ingredients used to manufacture Adderall. Albuterol is used to treat asthma, while Adderall is used to treat ADHD. Meg Oliver has more.
The maker of semaglutide tells CBS News it has ramped up production "24-hours, seven days a week" to meet expected demand in new markets.
Xylazine is "increasingly present" in the nation's drug supply and has been found in overdose deaths from coast to coast.
General Mills and other packaged-food giants say the government's push to tighten food labeling rules is unconstitutional.
Proposed legislation in California would ban five common chemicals from all goods sold, distributed or made in the state.
Abbott closed its Sturgis facility last year due to a bacteria outbreak, creating a nationwide formula shortage.
The recall applies to more than 302,000 bottles of the drink.
Authorities justify the ban, which mirrors mainland China's, by arguing that cannabidiol products could be converted into THC, the intoxicating compound in cannabis.
Agency says there's not enough evidence to determine how much CBD can be safely consumed, and has asked Congress to create new rules.
None of the contaminated products have been sold in the United States, the agency told CBS News.
Draft guidelines released by the agency on Tuesday outline a new maximum amount of lead that should be found in baby food.
A research organization plans to ask the FDA to approve the psychedelic drug as a prescription medication, in combination with therapy, to treat PTSD.
It's the second time in just a few months that products made by the same drugmaker have been linked to dozens of child deaths.
Pivotal results on a variety of next generation approaches are expected soon, as a panel of FDA advisers is set to weigh the future of immunization against SARS-CoV-2.
A new FDA-approved drug delays the onset of type 1 diabetes and the need for insulin injections for several years. Dr. Jon LaPook shows how it works and the potentially life-changing impact.
The agency said it will remove references on the contraception's packaging that claim, without scientific evidence, that the pill prevents a fertilized egg from implanting in the womb.
No hospitalizations or deaths related to the outbreak have been reported.
The Minnesota pharmaceutical board filed a lawsuit this week to stop the sale of edible cannabis products currently under investigation by the FDA.
The FDA is considering easing its restrictions on blood donations from gay and bisexual men. Dr. Céline Gounder, editor-at-large for public health at Kaiser Health News, joins CBS News to share her views on the likely change and why it's being considered now.
Under current federal rules, men cannot donate blood if they have had sex with another man in the last three months.
Online shoppers can already choose from more than a dozen self-testing kits, typically ranging in price from $69 to $500.
The Food and Drug Administration warned that overdoses from xylazine mirror opioid overdoses, but may not be reversed by naloxone.
Spray-on products including Not Your Mother's and Church & Dwight's Batiste found to contain cancer-causing chemical.
Dove, Nexxus and Suave are among recalled dry shampoo brands sold nationwide that may contain the human carcinogen.